Loading...
Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1
Historically, breast cancer has been regarded as an immunogenic “cold” tumor. However, the discovery of immune checkpoint inhibitors has made immunotherapy becoming an emerging new treatment modality for breast cancer. This review discusses the immune system, immune features of breast cancer, and th...
Saved in:
| Published in: | Chin Med J (Engl) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Wolters Kluwer Health
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7147660/ https://ncbi.nlm.nih.gov/pubmed/32106121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000000710 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|